Conference Detail Page

Molecular Tumor Board: Colon Adenocarcinoma, Endometrial Adenocarcinoma and Breast Invasive Ductal Carcinoam (IDC)

CME : 0.75
Start Date :  Feb 22 - 2019 End Date :  Feb 22 - 2020

Organized by :   Cancer Treatment Centers of America® (CTCA)

Specialities :   Oncology, Genetics

Conference Summary

Molecular Tumor Board: Colon Adenocarcinoma, Endometrial Adenocarcinoma and Breast Invasive Ductal Carcinoam (IDC) is organized by Cancer Treatment Centers of America® (CTCA).

Released: February 22, 2019
Expires: February 22, 2020

Intended Audience:
Physicians or other clinicians who particpate in molecular tumor boards.

Maximum Credits:
0.75 / AMA PRA Category 1 Credit.

Description:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: colon adenocarcinoma, endometrial adenocarcinoma, and breast invasive ductal carcinoma (IDC).

Educational Objectives:
Upon completion of this activity, participants will be able to:
• Utilize skills learned in this activity to implement an effective molecular tumor board
• Describe genomic testing and when it is appropriate to test
• Implement genomic profiling into oncology treatment and select the appropriate patient that is an ideal candidate for profiling

Credit Info

  • CME : 0.75
Speaker (s)
9 Speakers
Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat